Determination of the pharmacodynamic substances and mechanism of Shiwuwei Saierdou Pills against cholestatic hepatitis through chemical profile identification and network pharmacology analysis

化学 牛磺胆酸 药理学 轨道轨道 药效学 色谱法 广告 药代动力学 生物化学 胆汁酸 质谱法 体外 医学
作者
Jing Qin,Gelin Xiang,Hui‐Min Gao,Xianli Meng,Shaohui Wang,Yi Zhang
出处
期刊:Arabian Journal of Chemistry [Elsevier BV]
卷期号:17 (2): 105504-105504 被引量:7
标识
DOI:10.1016/j.arabjc.2023.105504
摘要

Cholestatic hepatitis (CH) is a liver lesion caused by abnormal bile production, secretion and excretion and has a complex pathogenesis. The Tibetan medicine Shiwuwei Saierdou Pills (SSP) is an empirical Tibetan medicine formula for the treatment of CH, but its chemical composition is complex and the material basis of its efficacy is not yet clear. So, in this study, the main chemical constituents and its blood-incorporated constituents in SSP were analyzed by ultra-high-performance liquid chromatography-quadruple-electrostatic field orbitrap high resolution mass spectrometry (UHPLC-Q-Exactive Orbitrap/MS), Then, the blood-incorporated constituents were subjected to network pharmacology analysis to preliminarily clarify its potential pharmacological substances and mechanism. and further, it was verified through molecular docking and in vivo animal experiments. As a result, a total of 80 chemical components were identified in the SSP, of which 11 were confirmed by reference standards and 20 blood-incorporated constituents (including 10 prototypes and 10 metabolites) were characterized in the serum containing the medicine. The core targets of SSP for the treatment of CH were identified as AKT1, VEGFA, CASP3, SRC and MAPK3 through the screening of the relationship between the blood-incorporated constituents and the targets. Combined with the results of molecular docking, swertiamarin, ellagic acid, taurocholic acid and bellidifolin in the ten prototypes may be the key pharmacodynamic substances for SSP to treat CH. The results of animal experiments showed that SSP could significantly inhibit the pathological changes of the CH rat model, and inhibit the protein expression of AKT1, VEGFA, CASP3, SRC and MAPK3. In summary, we used network pharmacology, molecular docking and animal experiments to preliminarily determine the main medicinal components, targets and pathways of SSP in the treatment of CH, which provides a scientific basis for further revealing the material basis and mechanism of SSP in treating CH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer的应助被chwa采纳,获得10
刚刚
秋风的应助被syr采纳,获得20
刚刚
莫语发布了新的文献求助10
1秒前
perry完成签到,获得积分10
1秒前
1秒前
EMMACao完成签到,获得积分10
2秒前
充电宝的应助被天真千易采纳,获得10
2秒前
wanci的应助被dhfify采纳,获得10
2秒前
ccc发布了新的文献求助10
2秒前
木木发布了新的文献求助10
2秒前
搜集达人的应助被青柳安采纳,获得10
2秒前
一一发布了新的文献求助40
2秒前
2秒前
2秒前
tyt完成签到 ,获得积分10
2秒前
2秒前
HJJHJH发布了新的文献求助20
2秒前
3秒前
衷燊完成签到,获得积分10
3秒前
岳圆发布了新的文献求助10
3秒前
3秒前
秋叶情安完成签到,获得积分10
3秒前
科研通AI6.2的应助被谨慎芷烟采纳,获得10
3秒前
赘婿的应助被李某某采纳,获得10
4秒前
张大山发布了新的文献求助10
4秒前
京城世界完成签到,获得积分10
4秒前
4秒前
暮冬十二完成签到 ,获得积分10
5秒前
北北完成签到 ,获得积分10
5秒前
5秒前
jiabaili完成签到,获得积分20
5秒前
5秒前
Su完成签到,获得积分10
5秒前
newman发布了新的文献求助10
6秒前
小二郎的应助被刘承昭采纳,获得10
6秒前
Run完成签到,获得积分10
6秒前
Ztx完成签到,获得积分10
6秒前
6秒前
小泓完成签到,获得积分10
6秒前
胡子发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707